Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (TOI) Interest & Investment Income (2020 - 2023)

Oncology Institute (TOI) has disclosed Interest & Investment Income for 3 consecutive years, with $940000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Interest & Investment Income changed N/A year-over-year to $940000.0, compared with a TTM value of $3.2 million through Sep 2023, up 54763.75%, and an annual FY2020 reading of $254149.0, changed N/A over the prior year.
  • Interest & Investment Income was $940000.0 for Q3 2023 at Oncology Institute, down from $1.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.2 million in Q1 2023 and bottomed at $5798.0 in Q3 2021.
  • Average Interest & Investment Income over 3 years is $349362.4, with a median of $66320.5 recorded in 2020.
  • Peak annual rise in Interest & Investment Income hit 7.67% in 2021, while the deepest fall reached 92.1% in 2021.
  • Year by year, Interest & Investment Income stood at $59248.0 in 2020, then plummeted by 90.21% to $5798.0 in 2021, then surged by 16112.49% to $940000.0 in 2023.
  • Business Quant data shows Interest & Investment Income for TOI at $940000.0 in Q3 2023, $1.0 million in Q2 2023, and $1.2 million in Q1 2023.